Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [HEALTH]
2 clusters · 2 sources · 26 days · First seen · Last updated
Public health and diagnostic challenges in Brazil
Overview
Health challenges in Brazil have been highlighted through studies on cancer diagnosis and rare disease management. Research from a hospital in Paraíba indicated that the COVID-19 pandemic caused a sharp decline in breast cancer diagnoses during 2020–2021, leading to patients being identified at more advanced clinical stages.
Further analysis of breast cancer in the country suggests that approximately 90% of cases are linked to lifestyle habits rather than heredity, with genetic factors accounting for only 5% to 10% of diagnoses. Experts emphasize that preventive measures such as physical activity and nutrition could reduce incidence by 35%.
Additionally, a national epidemiological study revealed significant delays in diagnosing rare diseases. The research found that over 17% of surveyed patients lacked a definitive diagnosis, with many waiting more than five years from symptom onset. These delays are attributed to a lack of specialized resources and genetic testing.
Entities
Brazil · Ministry of Health · Auxílio Emergencial · Rede Nacional de Doenças Raras · COVID-19 pandemic
Timeline
-
11 days ago
[HEALTH] 2 sourcesHealth challenges in Brazil: Lifestyle impacts breast cancer and rare disease diagnosis lagsHealth reports in Brazil highlight that 90% of breast cancer cases are linked to lifestyle habits, while a new study reveals significant delays and diagnostic gaps for patients with rare diseases.
-
about 1 month ago
[HEALTH] 2 sourcesBrazil's COVID-19 pandemic worsens breast cancer diagnosis and fuels massive emergency aidCOVID-19 in Brazil delayed breast cancer diagnoses in Paraíba and prompted a R$294 billion emergency aid program that reached 68 million people, affecting health outcomes and the economy.
Sources
amb.org.br · reportermt.com